Omnicell Inc

Chart & Performance

D1W1MN

P/E

—

P/S

1.78

EPS

—

Div Yield, %

0.00%

Shrs. gr., 5y

2.20%

Rev. gr., 5y

7.82%

Revenues

1.15b

-11.48%

Net income

-20m

CFO

181m

+132.83%

Earnings

Feb 06, 2025

Profile

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.

URL

https://www.omnicell.com/

IPO date

Aug 08, 2001

Employees

3,780

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12	2014‑12
Income
Revenues	1,147,112 -11.48%	1,295,947 14.48%	1,132,018 26.88%
Cost of revenue	744,298	811,929	653,081
Unusual Expense (Income)
NOPBT	402,814	484,018	478,937
NOPBT Margin	35.12%	37.35%	42.31%
Operating Taxes	263	(8,101)	(11,842)
Tax Rate	0.07%
NOPAT	402,551	492,119	490,779
Net income	(20,371) -460.68%	5,648 -92.74%	77,849 141.81%
Dividends
Dividend yield
Proceeds from repurchase of equity	15,850	(25,534)	51,062
BB yield	-0.93%	1.10%	-0.59%
Debt
Debt current	10,518	10,761	488,152
Long-term debt	637,482	645,381	79,822
Deferred revenue	58,622	37,385	20,194
Other long-term liabilities	6,318	6,719	7,839
Net debt	125,224	292,856	200,532
Cash flow
Cash from operating activities	181,094	77,781	231,809
CAPEX	(41,474)	(60,740)	(58,335)
Cash from investing activities	(55,016)	(58,669)	(412,498)
Cash from financing activities	23,420	(20,953)	47,363
FCF	403,154	394,247	527,363
Balance
Cash	467,972	330,362	349,051
Long term investments	54,804	32,924	18,391
Excess cash	465,420	298,489	310,841
Stockholders' equity	356,981	373,696	360,218
Invested Capital	1,511,003	1,482,847	1,388,173
ROIC	26.89%	34.28%	37.46%
ROCE	21.55%	27.14%	27.36%
EV
Common stock shares outstanding	45,212	45,891	47,943
Price	37.63 -25.37%	50.42 -72.06%	180.44 50.34%
Market cap	1,701,328 -26.47%	2,313,824 -73.25%	8,650,835 64.78%
EV	1,826,552	2,606,680	8,851,367
EBITDA	498,372	583,187	563,868
EV/EBITDA	3.67	4.47	15.70
Interest		130	23,500
Interest/NOPBT		0.03%	4.91%